Sign in
CompletedPhase 4

Dexmedetomidine for ESPB in Pain Management After Pediatric Idiopathic Scoliosis Surgery

Key facts

Who runs it
Poznan University of Medical Sciences
Where
Poland1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 4
People taking part
60 people enrolled
Started
1 Feb 2025
Ended
31 Mar 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Dexmedetomidine
  • 0.9%NaCl
Record updated
13 April 2026

Who can take part

Age
10 years to 18 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • children scheduled for idiopathic scoliosis surgery
  • age >10 and <18 years

Who cannot take part

  • steroid medication in regular use
  • infection at the site of the regional blockade
  • coagulation disorders
  • age < 10 years
  • age < 18 years
  • immunodeficiency
  • ASA= or >4

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Effect of perineurial dexmedetomidine on erector spinal plane block duration for pediatric, idiopathic scoliosis surgery.

The 2 groups in the trial

  • DEXMEDETOIDINEExisting treatment, for comparison

    0.2% ropivacaine 0.5ml/kg+ 0.1ug/kg Dexamethasone for erector spinae plane block

    Treatment: Dexmedetomidine

  • CONTROLExisting treatment, for comparison

    0.2% ropivacaine 0.5ml/kg for erector spinae plane block

    Treatment: 0.9%NaCl

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Dexmedetomidine for ESPB in Pain Management After Pediatric Idiopathic
Record updated
13 April 2026